CA Irvine의 다발성 골수종 임상 시험
다발성 골수종 관련 연구 13개가 Irvine 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
피험자 모집 중1상
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
피험자 모집 중1상
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
피험자 모집 중1/2상
- City of Hope Irvine Lennar, Irvine
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
피험자 모집 중3상
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
피험자 모집 중1/2상
- City of Hope - Lennar, Irvine
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
피험자 모집 중2상
- City of Hope at Irvine Lennar, Irvine
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중3상
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중3상
- UC Irvine Health Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
피험자 모집 중3상
- City of Hope - Lennar Foundation Cancer Center, Irvine
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
피험자 모집 중1/2상
- Research Site, Irvine
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
피험자 모집 중1/2상
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277911, Irvine
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
피험자 모집 중4상
- UCI Health - Irvine Infusion Pharmacy ACC, Irvine
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
피험자 모집 중관찰 연구건강한 지원자 환영
- City of Hope at Irvine Lennar, Irvine
다른 도시의 다발성 골수종 시험
- New York City, NY연구 60개
- Boston, MA연구 42개
- Atlanta, GA연구 41개
- Houston, TX연구 38개
- Durham, NC연구 37개
- Nashville, TN연구 32개
- Denver, CO연구 26개
- Rochester, MN연구 24개
- Columbus, OH연구 24개
- Baldwin Park, CA연구 23개
- St. Louis, MO연구 23개
- Chicago, IL연구 22개
Irvine의 다른 연구
- 비소세포폐암연구 25개
- 유방암연구 23개
- 암 (전체)연구 17개
- 전이성 암연구 16개
- 폐암연구 15개
- 전립선암연구 14개
- 난소암연구 12개
- 알츠하이머병연구 11개
- 두경부 편평세포암연구 11개
- 방광암연구 11개
- 췌장암연구 10개
- 자궁내막암연구 10개
ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.